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SummAry – Introduction: Papillary thyroid cancer is one of the cancers with favorable progno-
sis, although the long-term recurrence rate in the paratracheal region is reported to be as high as 30%. 
The use of ¹³¹i is considered to be a reliable treatment option for lymph node metastases in the para-
tracheal region. According to the majority of internationally accepted guidelines, it is not recom-
mended to perform central node dissection (Cnd) routinely. Total thyroidectomy (TT) remains an 
adequate treatment for these patients. According to many studies, Cnd is associated with higher rates 
of hypoparathyroidism. however, Cnd improves staging. Methods: we performed a retrospective 
study. we included 248 patients treated for papillary thyroid cancer during a 20-year period. data 
were collected on patient (age, sex) and tumor (size, focality) characteristics, presence of metastases in 
the central neck compartment, incidence of postoperative hypoparathyroidism, and locoregional fail-
ure. we divided patients into two groups based on pathological analysis: those without positive lymph 
nodes (n0) and those with positive paratracheal lymph nodes (n1). we compared patient and tumor 
characteristics and risk of recurrence between the two groups. Results: There were 39.5% patients with 
central neck metastases in our series. in the central neck dissection specimen, 5.5 nodes were found on 
average. hypoparathyroidism was found in 23.4% of patients and remained permanent in 3.2% of 
patients. Female and older patients had a lower chance of central compartment metastases, as did 
patients with smaller and unifocal tumors. recurrence risk was doubled for the n1 group. All tested 
differences between the groups reached statistical significance. Discussion and conclusion: in our hands, 
Cnd was a safe and effective surgical procedure. it improved staging and postsurgical management. 
efforts should be made to improve the preoperative work-up in order to more accurately identify 
high-risk patients. 
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Introduction
The overall incidence of papillary thyroid cancer 
(PTC) is increasing, with increases in the incidence 
rate and thyroid cancer mortality rate for advanced-
stage papillary thyroid cancer1. PTC is generally 
considered to have a favorable prognosis2. Some 
authors have proposed adjustments in workup, 
diagnosis, and management of PTC to accommodate 
the discovery that many thyroid cancers are low-risk 
and do not require aggressive, immediate intervention3. 
others have been pointing out that more than 10% of 
patients who died from thyroid cancer had tumors 
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smaller than 2 cm and underwent treatment4. The 
problem is how to recognize the group of patients at 
risk for an aggressive clinical course.
involvement of lymph nodes is very common, and, 
lymph node micrometastases are observed in up to 
80% of cases5. The long-term recurrence rate in the 
paratracheal region has been reported as being up to 
30%. Currently, there are no non- or minimally-
invasive methods that are completely reliable for 
detecting all of the metastases6. The radiological 
diagnostics of paratracheal space can represent a 
problem. it is a well-established fact that ultrasound 
(uS) is an excellent method for assessing lateral neck 
compartments. Additionally, it helps guide fine needle 
aspiration, which is vital for diagnosis and staging. 
however, the identification of lymph nodes in the 
central compartment is not always that simple. The 
percentage of lymph nodes detected in this region is 
reported to be up to 23.9%7 in the hands of an 
experienced radiologist using a high-quality high-
resolution ultrasound. A number of the lymph nodes 
go undetected due to their position beneath the thyroid 
gland. Furthermore, some nodes may be hard to detect 
because they may be overshadowed by artifacts due to 
bone structures or air. This is true for some nodes in 
region Vi, and it creates a particular problem in 
assessing region Vii involvement. As much as half of 
the nodes later found in surgery can be missed during 
the initial uS examination8. The assessment can also 
be compromised by the quality of the ultrasound 
machine as well as the subjectivity of the radiologist 
performing the uS.
during recent decades, the role of routine central 
lymph node dissection (Cnd) in the treatment of 
PTC has been an object of much study and remains 
controversial9. According to the majority of inter-
nationally accepted guidelines, it is not recommended 
to perform Cnd routinely. According to some authors, 
paratracheal metastases impact survival and Cnd 
lowers recurrence risk and prolongs disease free 
survival. Calo et al. compared rates of locoregional 
recurrence in patients treated with total thyroidectomy 
(TT) alone or in combination with bilateral or 
ipsilateral Cnd, but found no statistically significant 
differences between the groups10. TT with Cnd is 
associated with higher complication rates compared 
with TT alone, more often resulting in hypo-
parathyroidism than recurrence nerve palsy10. The 
risk-benefit analysis of neck dissection in patients with 
low-risk dTC showed no benefits in terms of complete 
remission or occurrence of progression, and risk of 
complications seems to be higher in patients with neck 
dissection11. Total thyroidectomy (TT) remains an 
adequate treatment for patients with PTC. The use of 
¹³¹i is considered a reliable treatment for lymph node 
metastases in the paratracheal region12,13.
Cnd improves staging, however. better preopera-
tive work-up and recognition of patients with higher 
risk for development of neck metastases could improve 
our surgical management. ipsilateral Cnd could bring 
the benefit of better staging without burden of a rising 
complication rate6,10.
Methods
we performed a retrospective study. we analyzed 
the records of 248 patients treated for PTC at the 
department of head and neck Surgery in the insti-
tute for Tumors of the “Sestre milosrdnice” university 
hospital during a 20-year period. we included all the 
patients that had preoperatively diagnosed PTC 
without clinical suspicion of either central or lateral 
neck metastases. All the patients received TT and 
Cnd. indication for Cnd was based on preoperative 
PTC diagnosis and intraoperative finding of suspicious 
lymph nodes. ipsilateral paratracheal and pretracheal 
spaces were routinely dissected. if any suspicious 
lymph nodes were observed in pretracheal or con-
tralateral paratracheal space, contralateral dissection 
was also performed. All the patients received follow-
up of at least one year. none of the patients had signs 
of disseminated disease during follow-up.
data was collected on patient (age, sex) and tumor 
(size, focality) characteristics, number of dissected 
lymph nodes, presence of metastases in the central 
neck compartment, incidence of postoperative hypo-
parathyroidism, and locoregional failure. we divided 
patients into two groups based on pathological analysis: 
those without positive paratracheal lymph nodes (n0) 
and those with positive paratracheal lymph nodes 
(n1). we compared patient (age, sex) and tumor 
characteristics and risk of recurrence between the two 
groups.
descriptive statistical methods were used to 
describe the study population. The chi-square test was 
used to test for the differences between the groups, 
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except in small observed frequencies when the yates 
corrected chi-square test was used. Statistical signi-
ficance was set at p<0.05. 
Results
we performed TT with Cnd in 248 patients with 
PTC.
There were 150 patients (60.5%) without and 98 
patients (39.5%) with central neck metastases.
in the whole group of patients, the mean age was 
49.4 (median 51, range 11 to 86 years); 150 patients 
(60.5%) were younger than 55 and 98 (39.5%) were 55 
or older. There were 48 men (19.4%) and 200 women 
(80.6%).
Average tumor size was 14.3 mm (median 12 mm, 
range 3 to 60 mm); 44.8 % of tumors were up to 10 
mm in size and 55.2% were larger than 10 mm. The 
majority of tumors was unifocal (68.1%).
Cnd was performed in all patients. on average, 
5.5 nodes were found per Cnd specimen, range 0-28 
per specimen, median 4. we found central neck 
metastases in 39.1% of patients.
hypoparathyroidism manifested in 23.4% of 
patients. eight patients (3.2%) had permanent 
hypoparathyroidism requiring vitamin d supplements.
we observed lateral neck recurrence in 17 patients 
during follow-up. in this group of patients, 4 had both 
central compartment and lateral neck recurrence. 
overall recurrence risk was 6.9%.
Further analysis was performed comparing the n0 
and n1 groups of patients.
in the n0 group of patients, we observed a higher 
proportion of older (70.4%) and female patients (64%) 
(Figure 1). The difference was statistically significant 
for both age (χ2=6.168; df=2; p=0.013) and sex 
(χ2=4.205; df=2; p=0.04). in the group of patients with 
tumors up to 1 cm in size we found metastases in 
26.1% of the patients, whereas in the group of patients 
with tumors larger than 1 cm metastases were found in 
almost 50% of patients. The difference between the 
groups was statistically significant (χ2=14.23; df=2; 
p<0.001), (Figure 2). Similarly, metastases were found 
in 32.5% of patients that had unifocal tumors and in 
53.2% of patients with multifocal tumors. The differ-
ence between groups was statistically significant 
(χ2=9.612; df=2; p=0.002) (Figure 2).
risk of recurrence was doubled for n1 patients, 
and the difference between the n0 and n1 groups was 
statistically significant (χ2=18.49; df=2; p<0.001).
Discussion
despite the overall favorable prognosis, some 
patients have PTC with a clinically aggressive course. 
our goal was to try to identify patients who are at risk 
and treat them more aggressively, possibly improving 
the course of the disease.
our finding of nearly 40% central compartment 
neck metastases in patients with PTC is consistent 
with literature data of 20-50% of lymph node 
involvement in most series. metastases can be present 
even when the primary tumor is small and 
intrathyroidal14.
According to the literature, PTC is diagnosed in 
women twice as often than in men, with a median age 
at diagnosis of about 45 years5. The median age was 
higher in our series, and only one fifth of the patients 
Figure 1. Patient age and sex in the N0 and N1 patient 
groups.
Figure 2. Size and focality of tumors in the N0 and N1 
patient groups.
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were men. This difference can be explained by the 
selection of a study group as clinically n0 PTC, 
because one expects more female and older patients in 
the group of patients with PTC with n0 lymph node 
status.
Compared with the series of machens et al., 
average tumor size in our series was smaller, the 
proportion of tumors smaller than 10 mm was higher, 
and multifocality was seen in more patients15. Although 
all tumor characteristics differ among published series, 
tumor multifocality shows the highest variability and 
is described in up to 85% of patients5.
it has been shown that the number of lymph nodes 
in the Cnd specimen is important in predicting 
central compartment recurrence16. The expected 
number of lymph nodes in the central neck com-
partment, according to a cadaveric study, is four (range 
1-16)17. in our series, we found 5.5 nodes per central 
neck dissection specimen, demonstrating the high 
quality of dissections.
All studies found greater rates of temporary 
hypoparathyroidism with Cnd6. Surgical treatment 
of thyroid carcinoma is associated with a greater rate 
of hypoparathyroidism when Cnd is added to 
thyroidectomy6. Transient hypoparathyroidism appea-
red in 23.4% of patients in our series and became 
permanent in 3.2% of patients. our result is compa-
rable to other studies6,18,19. use of different surgical 
techniques does not change the complication rates 
significantly20.
ryu et al. showed that male sex, tumor size larger 
than 1 cm, positive lymph nodes, lymphovascular 
invasion, and extrathyroidal extension are significantly 
associated with lateral neck ln recurrence21. data in 
our series were consistent with published data – risk of 
recurrence is doubled for n1 patients.
Although we are able to recognize tumors with 
higher metastatic potential after surgery and immu-
nohystochemical analysis, this does not help pre-
operative decision making. Some authors mention 
angiogenesis22, or more precisely matrix metallo-
proteinases and their inhibitors, regarding the deve-
lopment of lymph node metastases23.
diagnostic work up can also be improved in order 
to help the surgeon decide on the optimal operation 
plan for every patient. After identifying a patient with 
higher risk of central compartment metastases, mul-
tislice computed tomography (mSCT) can be perfor-
med (Figure 3). This diagnostic procedure is usually 
Figure 3. Contrast-enhanced MSCT  
(arrow points to an enlarged region VII lymphnode).
Figure 4. (A, B, C) Non enhanced MSCT. The figure shows good visibility of paratracehal and pretracheal lymphnodes 
even on a MSCT without intravenous contrast (arrows).
A b C
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avoided in patients with PTC because it is in most 
cases performed using an intravenous contrast agent 
which, consequently, delays the administration of ra-
dioactive iodine (rAi). however, the delay is 4-8 
weeks at most, with literature stating that a 4-week 
delay is sufficient24. This delay should not be consid-
ered a contraindication for performing mSCT since 
the data acquired from the procedure can change pa-
tient management. it is an especially important diag-
nostic procedure for patients with large tumors, tu-
mors with extrathyroidal spread, or patients with 
widely distributed nodal disease already identified 
with uS. in these patients, mSCT detects possible in-
volvement of not typically affected regions such as me-
diastinal, infra-clavicular, retropharynegeal and para-
pharyngeal regions, which cannot be adequately evalu-
ated using uS. mSCT is also more accurate in assess-
ing the central compartment25, especially region Vii 
which cannot be visualized with uS alone. Suspicious 
lymph nodes in this region seen on mSCT should al-
ter the surgical approach. Furthermore, this particular 
region can be also adequately assessed using a non-
contrast mSCT scan (Figure 4). The anatomy of the 
region allows an experienced radiologist to detect 
lymph nodes as small as 3 mm, even without the use of 
a contrast agent, thus eradicating the need for delay of 
rAi treatment in patients where it is necessary to ad-
minister the rAi treatment as soon as possible.
Conclusion
in our hands, Cnd has been a safe and effective 
surgical procedure. The question that has to be 
answered is whether it should be indicated in all 
patients with PTC and whether we can improve 
preoperative work-up to more accurately identify 
high-risk patients.
At the moment, Cnd significantly improves 
staging and enables more precise postsurgical 
management of patients with PTS.
Further analyses are necessary to answer whether 
ipsilateral Cnd can bring the benefit of better staging 
without the burden of a rising complication rate.
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Sažetak
ToTAlnA TiroideKTomiJA S diSeKCiJom CenTrAlne reGiJe VrATA  
u liJeČenJu PAPilArnoG KArCinomA ŠTiTnJAČe
M. Pastorčić Grgić, B. Stubljar, P. Perše, M. Zekan Vučetić i S. Šitić
Uvod: Papilarni karcinom štitnjače spada u tumore s povoljnom prognozom unatoč opisivanoj stopi recidiva u paratra-
healnoj regiji i do 30% slučajeva. radiojodna ablacija se smatra pouzdanom metodom liječenja metastaza u paratrahealnim 
čvorovima. Većina međunarodno prihvaćenih smjernica ne preporuča rutinsko izvođenje disekcije regije Vi (Cnd) već se 
samo totalna tireidektomija (TT) smatra adekvatnim liječenjem u ovoj skupini bolesnika. Prema mnogim studijama Cnd 
je povezana s višom pojavnošću hipoparatireoidizma. S druge strane, Cnd pomaže u utvrđivanju točnog staginga bolesti. 
Metode: Proveli smo retrospektivnu studiju u koju smo uključili 248 bolesnika koji su liječeni zbog papilarnog karcinoma 
štitnjače tijekom 20 godina. Podaci su analizirani temeljem karakteristika bolesnika (dob, spol), tumora (veličina, uni – i 
mutifokalnost), prisustva metastaza u centralnoj regiji vrata, incidencije postoperativnog hipoparatireoidizma i stope lokore-
gionalnog povrata bolesti. na osnovu patohistološkog nalaza podijelili smo bolesnike u dvije skupine: bolesnike bez pozitiv-
nih limfnih čvorova u regiji Vi (n0 skupina) kao i one s pozitivnim limfnim čvorovima u regiji Vi (n1 skupina). uspoređi-
vali smo osobine bolesnika i karakteristike tumora kao i rizik lokalnog recidiva bolesti između ove dvije skupine. Rezultati: 
u našoj seriji bilo je 39.5% bolesnika s metastazama u regiji Vi vrata čiji su disektati u prosjeku sadržavali 5.5 limfnih čvoro-
va. Postoperativni hipoparatireoidizam je verificiran kod 23.4% bolesnika, a ostao trajan u 3.2% bolesnika. Žene i bolesnici 
starije životne dobi imali su manji rizik od metastaza u regiju Vi, isto kao i bolesnici s manjim i unifokalnim tumorima. rizik 
povrata bolesti bio je udvostručen za n1 skupinu bolesnika. Sve analizirane razlike između skupina pokazale su statističku 
značajnost. Rasprava i zaključak: u našoj ustanovi Cnd smatramo sigurnom i učinkovitom operacijom koja poboljšava sta-
ging bolesti i time unapređuje daljnje liječenje bolesnika. nužno je poboljšati preoperativnu obradu kako bismo prepoznali 
bolesnike visokog rizika.
Ključne riječi: papilarni karcinom, disekcija regije VI
